Skip to main content
OpenTrials

Clinical trial condition

Chemically-Induced Disorders

Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.

7,317 public trials 1,008 recruiting studies
Refine in advanced search Browse all conditions

Chemically-Induced Disorders trial results

Completed

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

NCT01918852

Conditions
Chemically-Induced Disorders, Colonic Diseases, Colorectal Cancer, +22 more
Locations
  • Medisch Centrum Alkmaar Alkmaar, Netherlands
  • Meander Medisch Centrum Amersfoort, Netherlands
  • Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis Amsterdam, Netherlands
  • Academic Medical Centre Amsterdam, Netherlands
View all 24 locations
View Trial Details
Completed

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

NCT00156715

Conditions
Alcohol Abuse, Alcohol-Related Disorders, Alcoholism, +9 more
Locations
  • Medical College of Georgia Augusta, Georgia, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • West Central Behavioral Health Lebanon, New Hampshire, United States
  • Mental Health Center of Greater Manchester Manchester, New Hampshire, United States
View Trial Details
Completed

The Effectiveness of rTMS in Depressed VA Patients

NCT01191333

Conditions
Behavior, Behavioral Symptoms, Chemically-Induced Disorders, +12 more
Locations
  • VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States
  • San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States
  • Cincinnati VA Medical Center, Cincinnati, OH Cincinnati, Ohio, United States
  • Philadelphia VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

NCT00672477

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Salix Investigational Site Mobile, Alabama, United States
  • Salix Investigational Site Laguna Hills, California, United States
  • Salix Investigational Site Lancaster, California, United States
  • Salix Investigational Site Aurora, Colorado, United States
View all 60 locations
View Trial Details
Completed

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

NCT00672139

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Salix Investigational Site Mobile, Alabama, United States
  • Salix Investigational Site Laguna Hills, California, United States
  • Salix Investigational Site Lancaster, California, United States
  • Salix Investigational Site Aurora, Colorado, United States
View all 46 locations
View Trial Details

Related conditions